# Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

> **NCT01171469** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 8 (actual)

## Conditions studied

- Brain Tumor
- Glioblastoma
- Medulloblastoma
- Ependymoma
- Anaplastic Astrocytoma

## Interventions

- **BIOLOGICAL:** Dendritic Cells
- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT01171469
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171469, "Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01171469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*